Prevention of venous thromboembolism in orthopaedic patients.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000991:Antithrombins / Q000009:adverse effects / Q000627:therapeutic use; D001900:Boston; D002648:Child; D003911:Dextrans / Q000627:therapeutic use; D005340:Fibrinogen / Q000378:metabolism; D050723:Fractures, Bone / Q000601:surgery; D006470:Hemorrhage / Q000139:chemically induced; D006493:Heparin / Q000627:therapeutic use; D006621:Hip Joint / Q000601:surgery; D006801:Humans; D008875:Middle Aged; D009985:Orthopedics; D010690:Phlebography; D011183:Postoperative Complications / Q000517:prevention & control*; D011655:Pulmonary Embolism / Q000175:diagnosis; D013923:Thromboembolism / Q000453:epidemiology / Q000517:prevention & control*; D013924:Thrombophlebitis / Q000175:diagnosis / Q000453:epidemiology / Q000517:prevention & control
D000991:Antithrombins; D003911:Dextrans; D005340:Fibrinogen; D006493:Heparin